On Tuesday, Soleno Therapeutics Inc (NASDAQ: SLNO) opened higher 9.11% from the last session, before settling in for the closing price of $47.63. Price fluctuations for SLNO have ranged from $21.30 to $55.56 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -1.94% at the time writing. With a float of $25.93 million, this company’s outstanding shares have now reached $31.68 million.
In an organization with 42 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 41.09%, operating margin of -1982.56%, and the pretax margin is -1898.11%.
Soleno Therapeutics Inc (SLNO) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Soleno Therapeutics Inc is 33.29%, while institutional ownership is 80.54%. The most recent insider transaction that took place on Oct 07 ’24, was worth 125,204,132. Before that another transaction happened on Oct 01 ’24, when Company’s SEE REMARKS sold 3,108 for $49.43, making the entire transaction worth $153,627. This insider now owns 81,465 shares in total.
Soleno Therapeutics Inc (SLNO) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -1.94% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.00% during the next five years compared to 24.34% growth over the previous five years of trading.
Soleno Therapeutics Inc (NASDAQ: SLNO) Trading Performance Indicators
Check out the current performance indicators for Soleno Therapeutics Inc (SLNO). In the past quarter, the stock posted a quick ratio of 29.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.43, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -2.03 in one year’s time.
Technical Analysis of Soleno Therapeutics Inc (SLNO)
Let’s dig in a bit further. During the last 5-days, its volume was 1.2 million. That was better than the volume of 0.45 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 45.51%. Additionally, its Average True Range was 2.79.
During the past 100 days, Soleno Therapeutics Inc’s (SLNO) raw stochastic average was set at 75.65%, which indicates a significant increase from 53.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.79% in the past 14 days, which was higher than the 57.43% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $48.95, while its 200-day Moving Average is $45.12. However, in the short run, Soleno Therapeutics Inc’s stock first resistance to watch stands at $55.73. Second resistance stands at $59.50. The third major resistance level sits at $62.18. If the price goes on to break the first support level at $49.28, it is likely to go to the next support level at $46.60. Assuming the price breaks the second support level, the third support level stands at $42.83.
Soleno Therapeutics Inc (NASDAQ: SLNO) Key Stats
There are currently 33,411K shares outstanding in the company with a market cap of 2.02 billion. Presently, the company’s annual sales total 0 K according to its annual income of -38,990 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -21,850 K.
